> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Extended on Hatch-Waxman Act Meeting
- URL: https://www.fdaweb.com/comments-extended-on-hatch-waxman-act-meeting/
- Published: 2017-09-19T12:00:00.000Z
- Updated: 2026-09-14T22:51:21.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5139662

*Federal Register* notice: FDA is extending the comment period for the public meeting on “Administering the Hatch-Waxman Amendments: Ensuring a Balance Between Innovation and Access.” The agency is seeking public input to help ensure that the law’s intended balance between encouraging innovation in drug development and accelerating the availability to the public of lower cost alternatives to innovator drugs is maintained. Comments can be submitted either in electronic or written form by 11/17\. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-09-19/pdf/2017-19904.pdf?ref=fdaweb.com).